Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Stephen Wood

OTHER INVESTOR TYPE
Active STATUS
2 INVESTMENTS
1 PORTFOLIO
1 EXITS
Description

Mr. Stephen Wood serves as Director at Pentraxin Therapeutics.

Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
  • Wolfson Drug Discovery Unit Centre for Amyloidosis and Acute Phase Proteins
  • Division of Medicine, Royal Free Campus, University College London, Rowland Hill Street
  • London NW3 2PF
  • England, United Kingdom

Stephen Wood Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ffrees 24-Oct-2014 Early Stage VC 00.000 Other Commercial Banks Bankruptcy: Admin/Reorg 0000000 0000
000000000 00000000 00000 00000 Drug Discovery Generating Revenue 0000000 0000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Stephen Wood’s full profile, request a free trial.

Stephen Wood Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 29-Mar-2019 0000000000: 000000 Completed
To view this investor’s complete exits history, request access »

Stephen Wood Team (1)

Name Title Deals Funds Boards Office Contact
Info
Stephen Wood Angel Investor 0 0 London, United Kingdom